Saturday, January 07, 2023 6:06:11 PM
I posted information on surrendering shares. In order to understand surrendering shares one needs to be familiar with forfeiting shares since the two CAN BE related.
The information I posted is not the end all to end all. There could be other factors (rules, regs, laws) at play in Leo's decision that we're not aware of (we don't know what we don't know).
The link I posted explains forfeiture and surrender of shares. This article EXPLAINS and you characterized it as me (via my post) raising a forfeiture issue.
How you interpret information I post...is on you.
Message in reply to:
"Who said he was "forced." Who said the shares wasn't paid for?"
I thought that YOU did. You posted the link that says that a forfeiture occurs when shares that haven't been fully paid for are involuntarily returned to the Company.
"I am content to take Leo at his word that this is a personal tax situation."
So am I, but then your raising of the possibility that the return of shares may have been a forfeiture was irrelevant. It was a voluntary return of shares according to the man himself.
It was only your link that raised the forfeiture issue but if it turns out that there was an issue about his ownership of the shares based on the way he "paid" for them it wouldn't surprise me. I thought it was funky from the gitgo.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM